Respiratory Virus-Induced TLR7 Activation Controls IL-17–Associated Increased Mucus via IL-23 Regulation
暂无分享,去创建一个
G. Núñez | S. Mukherjee | N. Lukacs | D. Lindell | S. Morris | J. Smit
[1] K. Mills,et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. , 2009, Immunity.
[2] Qingshan Li,et al. AP-1 Activated by Toll-like Receptors Regulates Expression of IL-23 p19* , 2009, The Journal of Biological Chemistry.
[3] Jianping Jin,et al. IFN-β1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation1 , 2009, The Journal of Immunology.
[4] J. Crowe,et al. A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction , 2009, Journal of Virology.
[5] H. Jessen,et al. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression , 2009, AIDS.
[6] L. Guillot,et al. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model. , 2009, Vaccine.
[7] M. Clare-Salzler,et al. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .
[8] L. Anderson,et al. Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2 , 2008, Journal of Virology.
[9] O. Ramilo,et al. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus , 2008, Proceedings of the National Academy of Sciences.
[10] M. Schaller,et al. B Cell Antigen Presentation Promotes Th2 Responses and Immunopathology during Chronic Allergic Lung Disease , 2008, PloS one.
[11] M. Nyegaard,et al. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders , 2008, Thorax.
[12] E. Hollams,et al. Presymptomatic differences in Toll-like receptor function in infants who have allergy. , 2008, The Journal of allergy and clinical immunology.
[13] R. Coffman,et al. Development of TLR inhibitors for the treatment of autoimmune diseases , 2008, Immunological reviews.
[14] G. Matlashewski,et al. Immunization with a Toll-Like Receptor 7 and/or 8 Agonist Vaccine Adjuvant Increases Protective Immunity against Leishmania major in BALB/c Mice , 2008, Infection and Immunity.
[15] B. Williams,et al. TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages1 , 2008, The Journal of Immunology.
[16] T. Berg,et al. Association of TLR7 single nucleotide polymorphisms with chronic HCV‐infection and response to interferon‐a‐based therapy , 2007, Journal of viral hepatitis.
[17] J. Casanova,et al. Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses , 2007, Immunological reviews.
[18] T. Pollin,et al. Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children1 , 2007, The Journal of Immunology.
[19] P. Sly,et al. TLR4 Polymorphisms Mediate Impaired Responses to Respiratory Syncytial Virus and Lipopolysaccharide1 , 2007, The Journal of Immunology.
[20] S. Turvey,et al. Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. , 2007, Clinical immunology.
[21] A. Hata,et al. CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population. , 2007, The Journal of infectious diseases.
[22] S. Kunkel,et al. MyD88-Mediated Instructive Signals in Dendritic Cells Regulate Pulmonary Immune Responses during Respiratory Virus Infection1 , 2007, The Journal of Immunology.
[23] A. Prescott,et al. Proximal effects of Toll-like receptor activation in dendritic cells. , 2007, Current opinion in immunology.
[24] J. Price. Acute and long-term effects of viral bronchiolitis in infancy , 2007, Lung.
[25] A. Heinzmann,et al. TLR-4 and CD14 Polymorphisms in Respiratory Syncytial Virus Associated Disease , 2007, Disease markers.
[26] Allan R. Brasier,et al. Retinoic Acid-Inducible Gene I Mediates Early Antiviral Response and Toll-Like Receptor 3 Expression in Respiratory Syncytial Virus-Infected Airway Epithelial Cells , 2006, Journal of Virology.
[27] R. Peebles,et al. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. , 2006, The American journal of pathology.
[28] L. Cosmi,et al. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. , 2006, The Journal of allergy and clinical immunology.
[29] M. Boukhvalova,et al. Analysis of TLR4 Polymorphic Variants: New Insights into TLR4/MD-2/CD14 Stoichiometry, Structure, and Signaling1 , 2006, The Journal of Immunology.
[30] Zhengfan Jiang,et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. , 2006, Annual review of immunology.
[31] A. Gruber,et al. Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection , 2006, The Journal of Immunology.
[32] H. S. Warren,et al. Toll-like receptors. , 2005, Critical care medicine.
[33] B. Graham,et al. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. , 2005, The Journal of allergy and clinical immunology.
[34] J. Hiscott,et al. Gene Expression and Antiviral Activity of Alpha/Beta Interferons and Interleukin-29 in Virus-Infected Human Myeloid Dendritic Cells , 2005, Journal of Virology.
[35] Christophe Caux,et al. A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells , 2005, The Journal of experimental medicine.
[36] S. Finke,et al. Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus , 2005, Journal of Virology.
[37] C. Duckett,et al. Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression , 2005, Journal of Virology.
[38] M. Colonna,et al. Dendritic cells respond to influenza virus through TLR7‐ and PKR‐independent pathways , 2005, European journal of immunology.
[39] M. Buc,et al. Toll-like receptors. I. Structure, function and their ligands. , 2005, Folia biologica.
[40] M. Schaller,et al. Toll-like receptors as key mediators in innate antifungal immunity. , 2004, Medical mycology.
[41] N. Amariglio,et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. , 2004, The Journal of infectious diseases.
[42] N. Lukacs,et al. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.
[43] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Ehl,et al. The role of Toll‐like receptor 4 versus interleukin‐12 in immunity to respiratory syncytial virus , 2004, European journal of immunology.
[45] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[46] A. Gagro,et al. Increased Toll‐like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis , 2004, Clinical and experimental immunology.
[47] Tomoki Ito,et al. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9 , 2004, Springer Seminars in Immunopathology.
[48] R. Welliver. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. , 2003, The Journal of pediatrics.
[49] D. Olive,et al. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. , 2003, Journal of immunology.
[50] Y. Ho,et al. Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.
[51] G. Trinchieri,et al. Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.
[52] S. Akira,et al. Recognition of pathogen-associated molecular patterns by TLR family. , 2003, Immunology letters.
[53] R. Lemanske. The Childhood Origins of Asthma (COAST) study , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[54] R. Garofalo,et al. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. , 2002, The Journal of infectious diseases.
[55] N. Sigurs. A cohort of children hospitalised with acute RSV bronchiolitis: impact on later respiratory disease. , 2002, Paediatric respiratory reviews.
[56] S. Akira,et al. Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets , 2002, The Journal of experimental medicine.
[57] B. Graham,et al. The Role of IFN in Respiratory Syncytial Virus Pathogenesis , 2002, The Journal of Immunology.
[58] N. Sigurs. Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease , 2002, Respiratory research.
[59] L. Anderson,et al. Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus , 2001, Journal of Virology.
[60] J. Shellito,et al. Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.
[61] Douglas T. Golenbock,et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.
[62] L. O’Neill. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. , 2000, Biochemical Society transactions.
[63] J. Lötvall,et al. Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. , 2000, The Journal of allergy and clinical immunology.
[64] D. Sherrill,et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.
[65] J. Lötvall,et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.
[66] H. Maassab,et al. Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine. , 1999, Vaccine.